Joshua A Barocas Selected Research

Joshua A Barocas Research Topics

13	Opioid-Related Disorders (Opiate Addiction) 01/2023 - 09/2015
8	Opiate Overdose 05/2024 - 09/2015
4	Substance-Related Disorders (Drug Abuse) 05/2024 - 01/2020
3	Endocarditis 02/2022 - 01/2021
2	Communicable Diseases (Infectious Diseases) 01/2020 - 01/2019
2	Coinfection 10/2019 - 01/2019
2	Hepatitis C 10/2019 - 01/2019
1	Infections 01/2023
1	HIV Infections (HIV Infection) 04/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Anxiety Disorders (Anxiety Disorder) 10/2021
1	Soft Tissue Infections 01/2021
1	Mental Disorders (Mental Disorder) 01/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Fibrosis (Cirrhosis) 01/2019

14	Opioid Analgesics (Opioids)IBA 01/2023 - 01/2019
4	Buprenorphine (Subutex)FDA LinkGeneric 01/2023 - 10/2022
2	Naloxone Drug Combination Buprenorphine FDA Link 10/2022 - 10/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2022 - 02/2022
2	Naloxone (Narcan)FDA LinkGeneric 01/2021 - 09/2015
2	Illicit Drugs (Recreational Drugs)IBA 12/2020 - 01/2020
1	Fentanyl (Sublimaze)FDA LinkGeneric 11/2023
1	RV 538 (PDMP)IBA 01/2023
1	aducanumabIBA 01/2022
1	Nicotine FDA Link 10/2021
1	N-isobutyl-1,2-diphenylethanolamineIBA 01/2021
1	A-factor (Streptomyces)IBA 01/2019
1	ZincIBA 01/2019

2	Patient Readmission 01/2021 - 10/2020
1	Involuntary Commitment 05/2024
1	Catheters 02/2022
1	Therapeutics 02/2022
1	Ambulatory Care (Outpatient Care) 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Aftercare (After-Treatment) 12/2020
1	Continuity of Patient Care 01/2020